Welcome to our dedicated page for Fuller H B Co SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The H.B. Fuller Company (NYSE: FUL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. H.B. Fuller is a Minnesota-based issuer that describes itself as the largest pureplay adhesives company in the world, focused on adhesives, sealants, functional coatings and other chemical-based products.
Investors can use this page to access current and historical Forms 8‑K, which H.B. Fuller files to report material events such as quarterly and annual earnings releases, dividend declarations and board changes. Recent 8‑K filings referenced in the input include items under Item 2.02 – Results of Operations and Financial Condition and Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, along with exhibits that attach the related press releases.
In addition to event-driven reports, users can review the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available in the feed). These filings typically provide detailed information on net revenue, margins, net income, cash flow, segment performance, risk factors and other disclosures that complement the non‑GAAP metrics discussed in earnings releases and Regulation G reconciliation tables.
Stock Titan’s platform enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important changes from prior periods and clarify technical language. Real-time updates from EDGAR ensure that new H.B. Fuller filings appear promptly, while links to exhibits make it easier to connect narrative disclosures with supporting press releases and financial tables.
For users researching FUL, this page offers a focused view of H.B. Fuller’s regulatory history, from material event 8‑Ks to periodic reports, helping readers understand how the adhesives manufacturer describes its operations, financial condition, governance and risk profile in formal SEC documents.
Mastin Celeste Beeks, President and CEO of H.B. Fuller (FUL), reported multiple equity award transactions dated 01/24/2026. She settled 9,533 performance stock units and 4,213 restricted stock units into common shares at a reference price of
To cover taxes on the vested shares, Beeks had 1,791 and 3,937 common shares withheld, reducing the net shares retained. After these transactions, she directly owned 24,514 shares of common stock and indirectly held 3,500 shares through a revocable trust, while also maintaining sizeable employee stock options and restricted stock unit holdings that vest over future years.
H.B. Fuller VP, Corporate Controller Robert J. Martsching reported multiple equity award transactions dated 01/24/2026. He converted 440 performance stock units and 195 restricted stock units into common stock at $60.07 per share, and also acquired 17 common shares from dividend accruals during vesting. Footnotes state these units and restricted stock units convert into common stock on a 1-for-1 basis.
To cover taxes on the issuances, 56 shares and 163 shares of common stock were withheld, also at $60.07 per share. After the transactions, he directly owns 15,716.307 common shares. He also holds several fully vested employee stock options with exercise prices ranging from $45.05 to $77.72, as well as phantom units and additional restricted stock units that convert into common stock on a 1-for-1 basis under company plans.
H.B. Fuller Senior VP Malik Muhammad Shahbaz reported several equity award transactions in company stock. On 01/24/2026, 1,337 performance stock units and 591 restricted stock units converted into the same number of H.B. Fuller common shares at prices of $60.07 and $60.70 per share, respectively. An additional 52 shares of common stock were credited from dividend accruals during vesting, while 210 shares and 493 shares were withheld to cover taxes on shares issued. After these transactions, he directly owned 12,898 shares of H.B. Fuller common stock and continued to hold multiple vested and unvested stock options and restricted stock units convertible into common shares.
H.B. Fuller executive Du Xinyu reports routine equity transactions related to company stock and awards. As Sr. VP, Global R&D, Du converted 374 performance stock units and 162 restricted stock units into common shares on 01/24/2026 at a reference price of $60.07 per share. These awards convert into common stock on a 1-for-1 basis.
The filing also shows the acquisition of 5 common shares from dividend accruals during the vesting period, and share withholdings of 50 and 116 shares to cover taxes on issued stock. After these transactions, Du directly holds 2,629 shares of H.B. Fuller common stock.
Separately, Du holds several fully vested employee stock options and options vesting in three annual installments, plus restricted stock units that vest over time and include dividend-equivalent reinvestment features. No new option or RSU grants are reported in this filing.
H.B. Fuller senior vice president Joao Magalhaes reported multiple equity transactions on January 24, 2026. He converted 293 performance stock units and 130 restricted stock units into common shares at a reference price of $60.07 per share, consistent with the 1‑for‑1 conversion terms for these awards. He also acquired 11 additional common shares from dividend accruals during the vesting period.
To cover taxes on the shares issued, 62 and 144 common shares were withheld, leaving Magalhaes with 3,513 common shares held directly after the transactions. He also continues to hold several fully vested employee stock options and additional restricted stock units that will vest in three annual installments beginning on specified grant dates, providing potential future common stock if exercised or when vesting completes.
H.B. Fuller Executive VP and CFO John J. Corkrean reported multiple equity compensation transactions dated 01/24/2026. He acquired 2,943 shares of common stock from performance stock units and 1,301 shares from restricted stock units, both at a price of $60.07 per share. An additional 116 shares of common stock were credited based on dividend accruals during the vesting period.
To cover taxes on these issuances, 465 shares and 1,005 shares of common stock were withheld, each at $60.07 per share. After these transactions, Corkrean directly owned 57,536 shares of H.B. Fuller common stock. The filing also lists various fully vested and time-vested employee stock options, restricted stock units, performance units, and phantom units that are settled or convertible on a 1-for-1 basis into common stock under specified vesting and plan terms.
FULLER H B Executive Vice President, HHC, James J. East reported multiple equity award transactions dated January 24, 2026. Performance stock units covering 1,739 shares and restricted stock units covering 769 shares were exercised (code M) and converted into common stock at $60.07 per share. An additional 68 common shares were acquired from dividend accruals, while 185 and 568 shares were withheld (code F) to cover taxes.
Following these transactions, East directly owned 4,645 shares of common stock and had 106.19 common shares indirectly through a 401(k) plan. He also held employee stock options for 14,844, 8,834, 3,957 and 12,199 shares, phantom units equal to 4,135.7 shares, and restricted stock units totaling 1,405.15 and 2,640.43 shares, each generally converting into common stock on a 1-for-1 basis under the plans.
H.B. Fuller senior vice president Heather Campe reported multiple equity award transactions and updated share holdings. On January 24, 2026, she exercised 1,415 performance stock units and 625 restricted stock units, each converting into common stock on a 1-for-1 basis at a reported price of $60.07 per share. The filing also shows 56 common shares acquired from dividend accruals and common shares withheld to cover taxes on vested shares. After these transactions, she directly held about 23,785 common shares. Campe also holds several fully vested and time-vesting employee stock options, phantom units, and additional restricted stock units that convert into common stock on a 1-for-1 basis under the company’s compensation plans.
H.B. Fuller Company files its annual report describing a global adhesives and specialty chemicals business organized into Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Building Adhesive Solutions. The company operates in 44 countries with about 7,100 employees and generated roughly 56 percent of 2025 net revenue outside the U.S.
The report highlights sensitivity to raw material and currency movements: raw materials were about 75 percent of cost of sales, with a hypothetical 1 percent raw material cost change estimated to shift net income by
H.B. Fuller Company’s President and CEO, Celeste Beeks Mastin, reported an equity award and updated her holdings. On January 20, 2026, she received 9,533 Performance Stock Units, each representing a contingent right to receive one share of H.B. Fuller common stock, with vesting tied to return on invested capital at 80% of the target level on January 24, 2026. These units convert into common shares on a 1-for-1 basis.
After this award, she holds common stock directly and indirectly, including 16,119 shares of common stock held directly and 3,500 shares held indirectly through a revocable trust, as well as multiple employee stock options and restricted stock units that vest over time in three annual installments.